Edward Rockenstein

Active 1994–2023

125
Papers
30,017
Citations
89
h-index
125
i10-index

Citations

Citations per year for Edward Rockenstein1971: 1 citations1994: 6 citations1995: 24 citations1996: 34 citations1997: 35 citations1998: 39 citations1999: 46 citations2000: 83 citations2001: 161 citations2002: 192 citations2003: 221 citations2004: 264 citations2005: 248 citations2006: 325 citations2007: 308 citations2008: 336 citations2009: 399 citations2010: 500 citations2011: 515 citations2012: 541 citations2013: 547 citations2014: 579 citations2015: 546 citations2016: 401 citations2017: 442 citations2018: 421 citations2019: 1,309 citations2020: 1,328 citations2021: 1,160 citations2022: 928 citations2023: 670 citations2024: 857 citations2025: 388 citations2026: 7 citations1972–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,504 citing papers, 31% of this breakdownChina: 1,230 citing papers, 8.5% of this breakdownUnited Kingdom: 962 citing papers, 6.6% of this breakdownGermany: 866 citing papers, 6% of this breakdownItaly: 586 citing papers, 4% of this breakdownJapan: 513 citing papers, 3.5% of this breakdownCanada: 508 citing papers, 3.5% of this breakdownFrance: 419 citing papers, 2.9% of this breakdownSpain: 382 citing papers, 2.6% of this breakdownAustralia: 369 citing papers, 2.6% of this breakdownIndia: 354 citing papers, 2.4% of this breakdownSouth Korea: 307 citing papers, 2.1% of this breakdown
0%31%Other 24.3%

Fields

  • Medicine61.2%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Neuroscience13.8%
  • Immunology and Microbiology2.4%
  • Materials Science0.4%
  • Computer Science0.3%
  • Other1.5%

Topics

  • Alzheimer's disease research and treatments12.8%
  • Parkinson's Disease Mechanisms and Treatments10.8%
  • Neuroinflammation and Neurodegeneration Mechanisms4.3%
  • Nuclear Receptors and Signaling3.4%
  • Autophagy in Disease and Therapy3.2%
  • Nerve injury and regeneration2.9%
  • Other62.6%

Coauthors

All papers

Open in search
  1. High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

    Authors: , , , , , , , , , - Journal of Neuroscience 2000 cited by 1,868

  2. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2009 cited by 1,037

  3. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 1,475

  4. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

    Authors: , , , , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2016 cited by 386

  5. Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders

    Authors: , , , , , , , , - Science 2000 cited by 1,805

  6. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , - Autophagy 2017 cited by 266

  7. Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo

    Authors: , , , , , , , , , , , - Cell stem cell 2017 cited by 507

  8. Distinct RolesIn Vivofor the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein

    Authors: , , , , , , , - Journal of Neuroscience 2011 cited by 373

  9. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

    Authors: , , , , , , , , , , - Science 2005 cited by 1,236

  10. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases

    Authors: , , , , , , , , - Journal of Neuroscience 2009 cited by 582

  11. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease

    Authors: , , , , , , - Scientific Reports 2018 cited by 160

  12. Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters

    Authors: , , , , , , - Journal of Neuroscience Research 2002 cited by 509

  13. Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurobiology of Disease 2019 cited by 119

  14. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2008 cited by 1,055

  15. Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models

    Authors: , , , , , , , , , , , , , , - Journal of Neuroscience 2014 cited by 320

  16. Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2011 cited by 422

  17. α-Synuclein Sequesters Dnmt1 from the Nucleus

    Authors: , , , , , , , , - Journal of Biological Chemistry 2011 cited by 300

  18. Polyamine pathway contributes to the pathogenesis of Parkinson disease

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 159

  19. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation

    Authors: , , , , , , , , , , , , - Molecular Neurodegeneration 2018 cited by 156

  20. β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 615

  21. RETRACTED ARTICLE: Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology

    Authors: , , , , , , , , , - Acta Neuropathologica Communications 2017 cited by 202

  22. Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission

    Authors: , , , , , , , , - Journal of Neuroscience 2012 cited by 333

  23. RETRACTED: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

    Authors: , , , , , , , , , , , , , , , , - Brain 2014 cited by 241

  24. Increased BMP6 Levels in the Brains of Alzheimer's Disease Patients and APP Transgenic Mice Are Accompanied by Impaired Neurogenesis

    Authors: , , , , , , , - Journal of Neuroscience 2010 cited by 225